Dihydroergotamine (injection): Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Gerald Chi (talk | contribs)
CMEAdmin, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
17,702 edits
m Changed protection level for "Dihydroergotamine" ([Edit=Allow only autoconfirmed users] (expires 02:02, 19 February 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 02:02, 19 February 2014 (UTC)))
Pratik Bahekar (talk | contribs)
nocaptcha
3,696 edits
No edit summary
Line 1: Line 1:
__NOTOC__
{{XXXXX}}
{{CMG}}; {{AE}} {{PB}}
'''''For patient information about XXXXX, click [[XXXXX (patient information)|here]].'''''
{{SB}}
==Overview==
{{drugbox
{{drugbox
|IUPAC_name=
|IUPAC_name=
Line 24: Line 33:
|routes_of_administration=
|routes_of_administration=
}}
}}
{{CMG}}
 
 
 
 
 
 
'''Dihydroergotamine''' is an [[ergot]] alkaloid used to treat [[migraine]]s.
 
 
==Category==
 
==FDA Package Insert==
 
'''  [[XXXXX indications and usage|Indications and Usage]]'''
'''| [[XXXXX dosage and administration|Dosage and Administration]]'''
'''| [[XXXXX dosage forms and strengths|Dosage Forms and Strengths]]'''
'''| [[XXXXX contraindications|Contraindications]]'''
'''| [[XXXXX warnings and precautions|Warnings and Precautions]]'''
'''| [[XXXXX adverse reactions|Adverse Reactions]]'''
'''| [[XXXXX drug interactions|Drug Interactions]]'''
'''| [[XXXXX use in specific populations|Use in Specific Populations]]'''
'''| [[XXXXX overdosage|Overdosage]]'''
'''| [[XXXXX description|Description]]'''
'''| [[XXXXX clinical pharmacology|Clinical Pharmacology]]'''
'''| [[XXXXX nonclinical toxicology|Nonclinical Toxicology]]'''
'''| [[XXXXX clinical studies|Clinical Studies]]'''
'''| [[XXXXX how supplied storage and handling|How Supplied/Storage and Handling]]'''
'''| [[XXXXX patient counseling information|Patient Counseling Information]]'''
'''| [[XXXXX labels and packages|Labels and Packages]]'''
 
==Mechanism of Action==




Line 31: Line 70:




==References==
{{Reflist|2}}


[[Category:Drugs]]


{{Antimigraine preparations}}
{{Antimigraine preparations}}
Line 37: Line 80:
[[Category:Lysergamides]]
[[Category:Lysergamides]]


[[de:Dihydroergotamin]]
[[pl:Dihydroergotamina]]
[[pl:Dihydroergotamina]]


Revision as of 21:44, 11 February 2014


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about XXXXX, click here.

Synonyms / Brand Names:

Overview

Dihydroergotamine (injection)
Clinical data
ATC code
Pharmacokinetic data
Elimination half-life9 hours
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC33H37N5O5
Molar mass583.678 g/mol




Dihydroergotamine is an ergot alkaloid used to treat migraines.


Category

FDA Package Insert

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

Dihydroergotamine is an ergot alkaloid used to treat migraines.


References

Template:Antimigraine preparations


Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Dihydroergotamine_(injection)&oldid=942398"